Efficacy and Safety of Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder.

Trial Profile

Efficacy and Safety of Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 02 Jul 2012

At a glance

  • Drugs Etoricoxib (Primary)
  • Indications Musculoskeletal pain; Rheumatic disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Jul 2012 Actual patient number is 45 according to ClinicalTrials.gov.
    • 02 Jul 2012 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Jul 2012 Drug company (Merck) added to the associations as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top